Chaucer/Bates Accessories; Analysis of Proposed Consent Order To Aid Public Comment, 45425-45426 [2023-15053]
Download as PDF
Federal Register / Vol. 88, No. 135 / Monday, July 17, 2023 / Notices
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
[FR Doc. 2023–15068 Filed 7–14–23; 8:45 am]
BILLING CODE 6750–01–P
FEDERAL TRADE COMMISSION
[File No. 222 3163]
Chaucer/Bates Accessories; Analysis
of Proposed Consent Order To Aid
Public Comment
Federal Trade Commission.
Proposed consent agreement;
request for comment.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
Federal law prohibiting unfair or
deceptive acts or practices. The attached
Analysis of Proposed Consent Order to
Aid Public Comment describes both the
allegations in the complaint and the
terms of the consent order—embodied
in the consent agreement—that would
settle these allegations.
DATES: Comments must be received on
or before August 16, 2023.
ADDRESSES: Interested parties may file
comments online or on paper by
following the instructions in the
Request for Comment part of the
SUPPLEMENTARY INFORMATION section
below. Please write ‘‘Chaucer/Bates
Accessories; File No. 222 3163’’ on your
comment and file your comment online
at https://www.regulations.gov by
following the instructions on the webbased form. If you prefer to file your
comment on paper, please mail your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex C),
Washington, DC 20580.
FOR FURTHER INFORMATION CONTACT: Julia
Ensor (202–326–2377), Attorney,
Division of Enforcement, Bureau of
Consumer Protection, Federal Trade
Commission, 600 Pennsylvania Ave.
NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 6(f) of the Federal Trade
Commission Act, 15 U.S.C. 46(f), and
FTC Rule § 2.34, 16 CFR 2.34, notice is
hereby given that the above-captioned
consent agreement containing a consent
order to cease and desist, having been
filed with and accepted, subject to final
approval, by the Commission, has been
placed on the public record for a period
of 30 days. The following Analysis to
Aid Public Comment describes the
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:10 Jul 14, 2023
Jkt 259001
terms of the consent agreement and the
allegations in the complaint. An
electronic copy of the full text of the
consent agreement package can be
obtained at https://www.ftc.gov/newsevents/commission-actions.
You can file a comment online or on
paper. For the Commission to consider
your comment, we must receive it on or
before August 16, 2023. Write ‘‘Chaucer/
Bates Accessories; File No. 222 3163’’
on your comment. Your comment—
including your name and your State—
will be placed on the public record of
this proceeding, including, to the extent
practicable, on the https://
www.regulations.gov website.
Because of heightened security
screening, postal mail addressed to the
Commission will be subject to delay. We
strongly encourage you to submit your
comments online through the https://
www.regulations.gov website. If you
prefer to file your comment on paper,
write ‘‘Chaucer/Bates Accessories; File
No. 222 3163’’ on your comment and on
the envelope, and mail your comment to
the following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Ave. NW, Suite CC–
5610 (Annex C), Washington, DC 20580.
Because your comment will be placed
on the publicly accessible website at
https://www.regulations.gov, you are
solely responsible for making sure your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include sensitive personal information,
such as your or anyone else’s Social
Security number; date of birth; driver’s
license number or other State
identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure your
comment does not include sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule § 4.10(a)(2), 16 CFR
4.10(a)(2)—including competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule
§ 4.9(c). In particular, the written
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
45425
request for confidential treatment that
accompanies the comment must include
the factual and legal basis for the
request and must identify the specific
portions of the comment to be withheld
from the public record. See FTC Rule
§ 4.9(c). Your comment will be kept
confidential only if the General Counsel
grants your request in accordance with
the law and the public interest. Once
your comment has been posted on the
https://www.regulations.gov website—as
legally required by FTC Rule § 4.9(b)—
we cannot redact or remove your
comment from that website, unless you
submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule § 4.9(c), and
the General Counsel grants that request.
Visit the FTC website at https://
www.ftc.gov to read this document and
the news release describing the
proposed settlement. The FTC Act and
other laws the Commission administers
permit the collection of public
comments to consider and use in this
proceeding, as appropriate. The
Commission will consider all timely
and responsive public comments it
receives on or before August 16, 2023.
For information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
Analysis of Proposed Consent Order To
Aid Public Comment
The Federal Trade Commission (the
‘‘Commission’’) has accepted, subject to
final approval, an agreement containing
a consent order from Chaucer
Accessories, Inc., Bates Accessories,
Inc., Bates Retail Group, Inc., and
Thomas P. Bates (‘‘Respondents’’).
The proposed consent order has been
placed on the public record for 30 days
for receipt of comments by interested
persons. Comments received during this
period will become part of the public
record. After 30 days, the Commission
will again review the agreement and the
comments received and decide whether
it should withdraw from the agreement
or make final the agreement’s proposed
order.
This matter involves Respondents’
labeling and advertising of belts, shoes,
and other products as ‘‘Made in USA’’
or ‘‘Made in USA from Global
Materials.’’ According to the FTC’s
complaint, Respondents (1) advertised
certain products as made in the United
States even though, in numerous
instances, they were wholly imported or
incorporated significant imported
components, and (2) labeled and
advertised certain other products as
‘‘Made in USA from Global Materials’’
E:\FR\FM\17JYN1.SGM
17JYN1
ddrumheller on DSK120RN23PROD with NOTICES1
45426
Federal Register / Vol. 88, No. 135 / Monday, July 17, 2023 / Notices
even though, in numerous instances,
those products were wholly imported
with de minimis finishing in the United
States. The FTC’s complaint also alleges
that, by distributing promotional
materials containing misrepresentations
regarding the origin of their products,
Respondents provided trade customers
the means and instrumentalities for the
commission of deceptive act or
practices. Based on the foregoing, the
complaint alleges Respondents violated
Section 5 of the Federal Trade
Commission Act, 15 U.S.C. 45(a).
The proposed consent order contains
provisions designed to prevent
Respondents from engaging in similar
acts and practices in the future.
Consistent with the FTC’s Made in USA
Labeling Rule, 16 CFR part 323, and its
Enforcement Policy Statement on U.S.Origin Claims, Part I prohibits
Respondents from making U.S.-origin
claims for their products unless: (1) the
final assembly or processing of the
product occurs in the United States, all
significant processing that goes into the
product occurs in the United States, and
all or virtually all ingredients or
components of the product are made
and sourced in the United States; (2) a
clear and conspicuous qualification
appears immediately adjacent to the
representation that accurately conveys
the extent to which the product contains
foreign parts, ingredients or
components, and/or processing; or (3)
for a claim that a product is assembled
in the United States, the product is last
substantially transformed in the United
States, the product’s principal assembly
takes place in the United States, and
United States assembly operations are
substantial.
Part II prohibits Respondents from
making any representation about the
country of origin of a product or service,
unless the representation is not
misleading and Respondents have a
reasonable basis substantiating it. Part
III prohibits Respondents from
providing others with the means and
instrumentalities to make the claims
prohibited in Parts I or II.
Parts IV through V are monetary
provisions. Part IV imposes a judgment
of $191,481. Part V includes additional
monetary provisions relating to
collections. Part VI requires
Respondents to provide sufficient
customer information to enable the
Commission to administer consumer
redress, if appropriate.
Part VII is a notice provision requiring
Respondents to identify and notify
certain consumers of the FTC’s action
within 30 days after the issuance of the
order, or within 30 days of the
consumer’s identification, if identified
VerDate Sep<11>2014
17:10 Jul 14, 2023
Jkt 259001
later. Respondents are also required to
submit reports regarding their
notification program.
Parts VIII through IX are reporting and
compliance provisions. Part VIII
requires Respondents to acknowledge
receipt of the order, to provide a copy
of the order to certain current and future
principals, officers, directors, and
employees, and to obtain an
acknowledgement from each such
person that they have received a copy of
the order. Part IX requires Respondents
to file a compliance report within one
year after the order becomes final and to
notify the Commission within 14 days
of certain changes that would affect
compliance with the order. Part X
requires Respondents to maintain
certain records, including records
necessary to demonstrate compliance
with the order. Part XI requires
Respondents to submit additional
compliance reports when requested by
the Commission and to permit the
Commission or its representatives to
interview Respondents’ personnel.
Finally, Part XII is a ‘‘sunset’’
provision, terminating the order after 20
years, with certain exceptions.
The purpose of this analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the complaint
or proposed order, or to modify in any
way the proposed order’s terms.
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2023–15053 Filed 7–14–23; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
Healthcare Infection Control Practices
Advisory Committee (HICPAC). This is
a virtual meeting. The public is
welcomed to listen to the meeting via
Zoom; 500 teleconference lines are
available. Time will be available for
public comment. Registration is
required.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
The meeting will be held on
August 22, 2023, from 12 p.m. to 2:30
p.m., EDT.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
Please click the link below to join the
webinar: https://cdc.zoomgov.com/j/
1615322622?pwd=T1Vnci9IQVF6YS9
nQzBzTTlTZTQzZz09.
Meeting ID: 161 532 2622
Passcode: 36073986
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion
(DHQP), National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention, l600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia 30329.
Telephone (404) 718–8039; Email:
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, DHQP; the Director,
NCEZID; the Director, CDC; and the
Secretary, Department of Health and
Human Services, regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
Guideline Workgroup; National
Healthcare Safety Network Workgroup;
and Dental Unit Waterlines Guideline
Update. Agenda items are subject to
change as priorities dictate.
DATES:
Public Participation
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
Written Public Comment: The public
may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is August 25, 2023. All
E:\FR\FM\17JYN1.SGM
17JYN1
Agencies
[Federal Register Volume 88, Number 135 (Monday, July 17, 2023)]
[Notices]
[Pages 45425-45426]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15053]
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
[File No. 222 3163]
Chaucer/Bates Accessories; Analysis of Proposed Consent Order To
Aid Public Comment
AGENCY: Federal Trade Commission.
ACTION: Proposed consent agreement; request for comment.
-----------------------------------------------------------------------
SUMMARY: The consent agreement in this matter settles alleged
violations of Federal law prohibiting unfair or deceptive acts or
practices. The attached Analysis of Proposed Consent Order to Aid
Public Comment describes both the allegations in the complaint and the
terms of the consent order--embodied in the consent agreement--that
would settle these allegations.
DATES: Comments must be received on or before August 16, 2023.
ADDRESSES: Interested parties may file comments online or on paper by
following the instructions in the Request for Comment part of the
SUPPLEMENTARY INFORMATION section below. Please write ``Chaucer/Bates
Accessories; File No. 222 3163'' on your comment and file your comment
online at https://www.regulations.gov by following the instructions on
the web-based form. If you prefer to file your comment on paper, please
mail your comment to the following address: Federal Trade Commission,
Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC-5610
(Annex C), Washington, DC 20580.
FOR FURTHER INFORMATION CONTACT: Julia Ensor (202-326-2377), Attorney,
Division of Enforcement, Bureau of Consumer Protection, Federal Trade
Commission, 600 Pennsylvania Ave. NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant to Section 6(f) of the Federal
Trade Commission Act, 15 U.S.C. 46(f), and FTC Rule Sec. 2.34, 16 CFR
2.34, notice is hereby given that the above-captioned consent agreement
containing a consent order to cease and desist, having been filed with
and accepted, subject to final approval, by the Commission, has been
placed on the public record for a period of 30 days. The following
Analysis to Aid Public Comment describes the terms of the consent
agreement and the allegations in the complaint. An electronic copy of
the full text of the consent agreement package can be obtained at
https://www.ftc.gov/news-events/commission-actions.
You can file a comment online or on paper. For the Commission to
consider your comment, we must receive it on or before August 16, 2023.
Write ``Chaucer/Bates Accessories; File No. 222 3163'' on your comment.
Your comment--including your name and your State--will be placed on the
public record of this proceeding, including, to the extent practicable,
on the https://www.regulations.gov website.
Because of heightened security screening, postal mail addressed to
the Commission will be subject to delay. We strongly encourage you to
submit your comments online through the https://www.regulations.gov
website. If you prefer to file your comment on paper, write ``Chaucer/
Bates Accessories; File No. 222 3163'' on your comment and on the
envelope, and mail your comment to the following address: Federal Trade
Commission, Office of the Secretary, 600 Pennsylvania Ave. NW, Suite
CC-5610 (Annex C), Washington, DC 20580.
Because your comment will be placed on the publicly accessible
website at https://www.regulations.gov, you are solely responsible for
making sure your comment does not include any sensitive or confidential
information. In particular, your comment should not include sensitive
personal information, such as your or anyone else's Social Security
number; date of birth; driver's license number or other State
identification number, or foreign country equivalent; passport number;
financial account number; or credit or debit card number. You are also
solely responsible for making sure your comment does not include
sensitive health information, such as medical records or other
individually identifiable health information. In addition, your comment
should not include any ``trade secret or any commercial or financial
information which . . . is privileged or confidential''--as provided by
section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule Sec.
4.10(a)(2), 16 CFR 4.10(a)(2)--including competitively sensitive
information such as costs, sales statistics, inventories, formulas,
patterns, devices, manufacturing processes, or customer names.
Comments containing material for which confidential treatment is
requested must be filed in paper form, must be clearly labeled
``Confidential,'' and must comply with FTC Rule Sec. 4.9(c). In
particular, the written request for confidential treatment that
accompanies the comment must include the factual and legal basis for
the request and must identify the specific portions of the comment to
be withheld from the public record. See FTC Rule Sec. 4.9(c). Your
comment will be kept confidential only if the General Counsel grants
your request in accordance with the law and the public interest. Once
your comment has been posted on the https://www.regulations.gov
website--as legally required by FTC Rule Sec. 4.9(b)--we cannot redact
or remove your comment from that website, unless you submit a
confidentiality request that meets the requirements for such treatment
under FTC Rule Sec. 4.9(c), and the General Counsel grants that
request.
Visit the FTC website at https://www.ftc.gov to read this document
and the news release describing the proposed settlement. The FTC Act
and other laws the Commission administers permit the collection of
public comments to consider and use in this proceeding, as appropriate.
The Commission will consider all timely and responsive public comments
it receives on or before August 16, 2023. For information on the
Commission's privacy policy, including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/site-information/privacy-policy.
Analysis of Proposed Consent Order To Aid Public Comment
The Federal Trade Commission (the ``Commission'') has accepted,
subject to final approval, an agreement containing a consent order from
Chaucer Accessories, Inc., Bates Accessories, Inc., Bates Retail Group,
Inc., and Thomas P. Bates (``Respondents'').
The proposed consent order has been placed on the public record for
30 days for receipt of comments by interested persons. Comments
received during this period will become part of the public record.
After 30 days, the Commission will again review the agreement and the
comments received and decide whether it should withdraw from the
agreement or make final the agreement's proposed order.
This matter involves Respondents' labeling and advertising of
belts, shoes, and other products as ``Made in USA'' or ``Made in USA
from Global Materials.'' According to the FTC's complaint, Respondents
(1) advertised certain products as made in the United States even
though, in numerous instances, they were wholly imported or
incorporated significant imported components, and (2) labeled and
advertised certain other products as ``Made in USA from Global
Materials''
[[Page 45426]]
even though, in numerous instances, those products were wholly imported
with de minimis finishing in the United States. The FTC's complaint
also alleges that, by distributing promotional materials containing
misrepresentations regarding the origin of their products, Respondents
provided trade customers the means and instrumentalities for the
commission of deceptive act or practices. Based on the foregoing, the
complaint alleges Respondents violated Section 5 of the Federal Trade
Commission Act, 15 U.S.C. 45(a).
The proposed consent order contains provisions designed to prevent
Respondents from engaging in similar acts and practices in the future.
Consistent with the FTC's Made in USA Labeling Rule, 16 CFR part 323,
and its Enforcement Policy Statement on U.S.-Origin Claims, Part I
prohibits Respondents from making U.S.-origin claims for their products
unless: (1) the final assembly or processing of the product occurs in
the United States, all significant processing that goes into the
product occurs in the United States, and all or virtually all
ingredients or components of the product are made and sourced in the
United States; (2) a clear and conspicuous qualification appears
immediately adjacent to the representation that accurately conveys the
extent to which the product contains foreign parts, ingredients or
components, and/or processing; or (3) for a claim that a product is
assembled in the United States, the product is last substantially
transformed in the United States, the product's principal assembly
takes place in the United States, and United States assembly operations
are substantial.
Part II prohibits Respondents from making any representation about
the country of origin of a product or service, unless the
representation is not misleading and Respondents have a reasonable
basis substantiating it. Part III prohibits Respondents from providing
others with the means and instrumentalities to make the claims
prohibited in Parts I or II.
Parts IV through V are monetary provisions. Part IV imposes a
judgment of $191,481. Part V includes additional monetary provisions
relating to collections. Part VI requires Respondents to provide
sufficient customer information to enable the Commission to administer
consumer redress, if appropriate.
Part VII is a notice provision requiring Respondents to identify
and notify certain consumers of the FTC's action within 30 days after
the issuance of the order, or within 30 days of the consumer's
identification, if identified later. Respondents are also required to
submit reports regarding their notification program.
Parts VIII through IX are reporting and compliance provisions. Part
VIII requires Respondents to acknowledge receipt of the order, to
provide a copy of the order to certain current and future principals,
officers, directors, and employees, and to obtain an acknowledgement
from each such person that they have received a copy of the order. Part
IX requires Respondents to file a compliance report within one year
after the order becomes final and to notify the Commission within 14
days of certain changes that would affect compliance with the order.
Part X requires Respondents to maintain certain records, including
records necessary to demonstrate compliance with the order. Part XI
requires Respondents to submit additional compliance reports when
requested by the Commission and to permit the Commission or its
representatives to interview Respondents' personnel.
Finally, Part XII is a ``sunset'' provision, terminating the order
after 20 years, with certain exceptions.
The purpose of this analysis is to aid public comment on the
proposed order. It is not intended to constitute an official
interpretation of the complaint or proposed order, or to modify in any
way the proposed order's terms.
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2023-15053 Filed 7-14-23; 8:45 am]
BILLING CODE 6750-01-P